Valo Health stock
Private-market facts for current and former Valo Health employees researching their stock.
Overview
AI-driven drug discovery and development company using human-centric data and computational models to identify novel therapeutics for cardiovascular and oncology diseases.
Valo Health outlook
For employees evaluating Valo Health equity, a 1x base multiple suggests the stock may be close to fairly valued at current prices. The upside scenario at 3x is relatively close to the base case, suggesting more predictable but narrower range of outcomes.
These estimates reflect modeled return scenarios, not guaranteed outcomes. Actual results depend on company performance, market conditions, share class, and timing.
Selling Valo Health shares
Why shareholders consider selling
Shareholders in Valo Health may explore liquidity for a number of reasons — diversifying a concentrated position, funding a personal financial goal, or simply reducing exposure to a single private holding. As a private company, Valo Health does not trade on a public exchange, meaning employees and early shareholders cannot simply sell through a brokerage. Extended private timelines can leave shareholders waiting years for an exit event, which is why some choose to explore secondary-market options.
Can you sell Valo Health stock?
Whether a shareholder can sell typically depends on what they hold and how it was acquired. Vested and exercised shares are generally more straightforward than unexercised options or unvested RSUs. Most private companies, including those in the Healthcare & Biotech sector, impose transfer restrictions such as rights of first refusal or board approval requirements. The specific terms governing Valo Health shares would be outlined in the holder's equity agreement or the company's governing documents.
What affects the value of Valo Health shares?
The price a buyer is willing to pay for private shares is shaped by several factors: overall demand for the stock, the company's financial performance, broader Healthcare & Biotech market conditions, and any recent private-market transaction activity. Data points such as the company's Series B round can help frame expectations, though they do not guarantee a transaction price.
What should holders check before selling
- The type of security held (common shares, preferred, options, RSUs)
- Whether the equity is fully vested and, for options, whether it has been exercised
- Any transfer restrictions, lock-up provisions, or company approval requirements
- Estimated net proceeds after applicable taxes and transaction fees
- Whether partial liquidity — selling a portion rather than the full position — may be a better fit
Tools for Valo Health shareholders
Exploring equity in Valo Health often raises questions about taxes, exercise timing, valuation, and exit outcomes. These tools can help you model different decisions using your own assumptions.
Latest funding round
Valo Health most recently raised a Series B round . Total funding raised to date is approximately $397M.
Lead investors in this round include General Atlantic and Koch Disruptive Technologies.
Founders & company background
Valo Health was founded in 2019 by David Berry and is headquartered in Boston, MA.
Investors
Industry
Similar private companies
Latest Valo Health news
Frequently asked questions
- Is Valo Health still a private company?
- Yes, Valo Health is currently a private company.
- What is Valo Health's latest funding round?
- Valo Health's most recent known round is Series B.
- What is Valo Health's valuation?
- Valo Health's valuation has not been publicly disclosed.
- Who are the investors in Valo Health?
- Notable investors include General Atlantic, Koch Disruptive Technologies.
- Can I sell my Valo Health stock?
- Private company shares can sometimes be sold on secondary markets. Speaking with a specialist who understands Valo Health stock can help you evaluate your options.
Related pages
Last verified: 2026-04-13 · Valo Health data compiled from funding disclosures, investor announcements, corporate filings, and public records.
Information on this page is compiled from publicly available sources and may be outdated or incomplete. This is not investment advice. Consult a qualified advisor before making financial decisions.